The intron 3 16 bp duplication polymorphism of p53 (rs17878362) is not associated with increased risk of developing triple-negative breast cancer.
Brianna C MortenSimon ChiuChristopher OldmeadowJan LubinskiRodney J ScottKelly A Avery-KiejdaPublished in: Breast cancer research and treatment (2018)
Taken together, our results do not support an association of the PIN3 genotype with increased breast cancer risk, either in ER-positive or ER-negative patients.